PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Completed

Phase 4 Results

Summary of Purpose

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 April 2014.

1 Aug 2003 9 Sep 2005 1 Apr 2008 Unavailable 1 Apr 2014 6 Feb 2009
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors See All

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Beth Gervers Investigator Relations Patient Recruitment Specialist Kendle International Phone: 614-865-0473

    hans.diener@uni-duisburg-essen.de